Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-13

Clinical Trial Update: Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

This clinical trial update reports an ongoing Phase 3 study assessing the efficacy and safety of HUC3-637 for Primary Open Angle Glaucoma and Ocular Hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HUC3-637

Snippet

Sponsor: Huons Co., Ltd. | Conditions: Primary Open Angle Glaucoma (POAG), Ocular Hypertension | Phase 3 | Status: RECRUITING